Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

10126

1

Schrodinger, Inc. Schrödinger, Inc. Reports 17% Decline in Revenue for Q3 2024, Net Loss Improves

Via official filing (AI summary) | 6 months ago | 0 comments

10127

1

Neuronetics, Inc. Neuronetics Reports Mixed Q3 2024 Results with Revenue Growth and Increased Loss

Via official filing (AI summary) | 6 months ago | 0 comments

10128

1

Centessa Pharmaceuticals plc Centessa Pharmaceuticals Reports Q3 2024 Financial Results, Net Losses, and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

10129

1

Scholar Rock Holding Corp Scholar Rock Reports Significant Decline in Assets, Increased Operating Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10130

1

GLOBAL TECHNOLOGIES LTD Global Technologies, Ltd. Reports Revenue Growth, Improved Operating Efficiency, and Strategic Acquisitions in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10131

1

Viridian Therapeutics, Inc.\DE Viridian Therapeutics Reports Increased Assets, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10132

1

Apogee Therapeutics, Inc. Apogee Therapeutics Reports Significant Financial Developments, Increased Expenses, and Net Losses

Via official filing (AI summary) | 6 months ago | 0 comments

10133

1

iTeos Therapeutics, Inc. iTeos Therapeutics Reports 178% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10134

1

ROCKWELL MEDICAL, INC. Rockwell Medical Reports 19% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10135

1

ASHFORD HOSPITALITY TRUST INC Ashford Hospitality Trust Reports Mixed Q3 2024 Results, Net Income Turnaround for Nine-Month Period

Via official filing (AI summary) | 6 months ago | 0 comments

10136

1

Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals Reports Improved Financials, Reduced Losses, and Increased Cash Reserves

Via official filing (AI summary) | 6 months ago | 0 comments

10137

1

Fathom Holdings Inc. Fathom Holdings Reports Decline in Revenue and Increased Net Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10138

1

US ENERGY CORP U.S. Energy Corp. Reports 43% Revenue Decline, Operating Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10139

1

Crescent Capital BDC, Inc. Crescent Capital BDC Reports Strong Growth in Investment Income and Net Assets for Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10140

1

NET Power Inc. NET Power Reports Revenue Growth, Reduced Losses in Q3 2024, Prepares for Utility-Scale Power Plant Construction

Via official filing (AI summary) | 6 months ago | 0 comments

10141

1

Nuvalent, Inc. Nuvalent Reports Significant Asset Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10142

1

AVANT TECHNOLOGIES INC. Avant Technologies Reports Significant Financial Challenges, Net Loss, and Accumulated Deficit in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

10143

1

Rigetti Computing, Inc. Rigetti Computing Reports Decline in Revenue and Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10144

1

SpringWorks Therapeutics, Inc. SpringWorks Therapeutics Reports Decrease in Cash and Cash Equivalents, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10145

1

Atlantis Glory Inc. Atlantis Glory Inc. Reports Financial Results, Net Loss, and Cash Flow Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

10146

1

Pactiv Evergreen Inc. Pactiv Evergreen Reports Decline in Financial Performance for Q3 and Nine Months of 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10147

1

TEAM INC Team, Inc. Reports Mixed Q3 Results with Revenue Growth and Improved Operating Income, but Net Loss and Equity Decline

Via official filing (AI summary) | 6 months ago | 0 comments

10148

1

Inhibitor Therapeutics, Inc. Inhibitor Therapeutics Reports Financial Results, Focuses on Cancer Treatment Development

Via official filing (AI summary) | 6 months ago | 0 comments

10149

1

Golden Star Resource Corp. Golden Star Resource Corp. Reports Net Loss, Increased Liabilities, and Cash Deficit in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10150

1

Live Nation Entertainment, Inc. Live Nation Entertainment Reports Mixed Q3 2024 Results, Revenue Decline and Increased Debt

Via official filing (AI summary) | 6 months ago | 0 comments